How will society allocate resources to expensive new technologies?
Small size of the Canadian biotech market is a constraint to the development of future technology
- Canada represents only about 2% of world-wide demand for biopharmaceutical products
Canadian-based companies need to sell in Canada in order to grow their global businesses